Literature DB >> 18351589

Role of structural water molecule in HIV protease-inhibitor complexes: a QM/MM study.

Cherumuttathu H Suresh1, Aswathy Mary Vargheese, K Periya Vijayalakshmi, Neetha Mohan, Nobuaki Koga.   

Abstract

Structural water molecule 301 found at the interface of HIV protease-inhibitor complexes function as a hydrogen bond (H-bond) donor to carbonyl groups of the inhibitor as well as H-bond acceptor to amide/amine groups of the flap region of the protease. In this study, six systems of HIV protease-inhibitor complexes were analyzed, which have the presence of this "conserved" structural water molecule using a two-layer QM/MM ONIOM method. The combination of QM/MM and QM method enabled the calculation of strain energies of the bound ligands as well as the determination of their binding energies in the ligand-water and ligand-water-protease complexes. Although the ligand experiences considerable strain in the protein bound structure, the H-bond interactions through the structural water overcomes this strain effect to give a net stability in the range of 16-24 kcal/mol. For instance, in 1HIV system, the strain energy of the ligand was 12.2 kcal/mol, whereas the binding energy associated with the structural water molecule was 20.8 kcal/mol. In most of the cases, the calculated binding energy of structural water molecule showed the same trend as that of the experimental binding free energy values. Further, the classical MD simulations carried out on 1HVL system with and without structural water 301 showed that this conserved water molecule enhances the H-bond dynamics occurring at the Asp-bound active site region of the protease-inhibitor system, and therefore it will have a direct influence on the mechanism of drug action. 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351589     DOI: 10.1002/jcc.20961

Source DB:  PubMed          Journal:  J Comput Chem        ISSN: 0192-8651            Impact factor:   3.376


  7 in total

1.  Transition states of native and drug-resistant HIV-1 protease are the same.

Authors:  D Randal Kipp; Jennifer S Hirschi; Aya Wakata; Harris Goldstein; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

2.  Computational analysis of aspartic protease plasmepsin II complexed with EH58 inhibitor: a QM/MM MD study.

Authors:  Natália de Farias Silva; Jerônimo Lameira; Cláudio Nahum Alves
Journal:  J Mol Model       Date:  2011-01-25       Impact factor: 1.810

3.  Reproducing crystal binding modes of ligand functional groups using Site-Identification by Ligand Competitive Saturation (SILCS) simulations.

Authors:  E Prabhu Raman; Wenbo Yu; Olgun Guvench; Alexander D Mackerell
Journal:  J Chem Inf Model       Date:  2011-04-01       Impact factor: 4.956

4.  Noscapinoids with anti-cancer activity against human acute lymphoblastic leukemia cells (CEM): a three dimensional chemical space pharmacophore modeling and electronic feature analysis.

Authors:  Pradeep K Naik; Seneha Santoshi; Harish C Joshi
Journal:  J Mol Model       Date:  2011-04-27       Impact factor: 1.810

5.  Analysis of structural water and CH···π interactions in HIV-1 protease and PTP1B complexes using a hydrogen bond prediction tool, HBPredicT.

Authors:  Joshy P Yesudas; Fareed Bhasha Sayyed; Cherumuttathu H Suresh
Journal:  J Mol Model       Date:  2010-05-19       Impact factor: 1.810

Review 6.  Quantum mechanics implementation in drug-design workflows: does it really help?

Authors:  Olayide A Arodola; Mahmoud Es Soliman
Journal:  Drug Des Devel Ther       Date:  2017-08-31       Impact factor: 4.162

7.  Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase.

Authors:  Collins U Ibeji; Nor Amirah Mohd Salleh; Jia Siang Sum; Angela Chiew Wen Ch'ng; Theam Soon Lim; Yee Siew Choong
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.